Background Phospholipase C-γl (PLC-γl) is known to play a critical role in cell adhesion and migration and is highly expressed in metastatic tumors. In the current study, we found that cells transformed by PLC-γl overexpression (PLC-γl cells) exhibited a marked decrease in expression of the Epo receptor (EpoR). Here, we assessed the role of EpoR-dependent signaling pathways in PLC-γl-dependent regulation of cell adhesion and migration. Methods Expression and phosphorylation of EpoR and its functional role in PLC-γl cells were evaluated by immunoblot analysis or cell adhesion assay. The mechanism for PLC-γ1-induced EpoR downregulation was analyzed by blockage of proteosomal degradation with MG132. EpoR expression was also confirmed in colorectal cancer tissues in which PLC-γl was highly expressed.
inositol 1.4.5-trisphosphate and diacylglycerol [1] [2] [3] . This has been shown to regulate cell proliferation [1] , mitogenic signals [2] , and cellular transformation in various cell types [3, 4] . Marked upregulation of PLC-γl has been demonstrated in colorectal cancer tissue [5, 6] and breast carcinoma [7] , but the actual PLC-γl-mediated signaling cascades associated with cell adhesion and migration have not been studied in detail. To investigate the signaling events involved in PLC-γ1-mediated regulation of cell adhesion and migration, 3Y1 fibroblasts transformed by PLC-γ1 overexpression (PLC-γ1 cells) and vector control cells (vector cells) were used [2, 3] .
Erythropoietin (Epo), which is the principal growth factor responsible for promoting the viability, proliferation, and differentiation of mammalian erythroid precursor cells, exerts its effects by binding to the erythropoietin receptor (EpoR) [8] [9] [10] [11] . EpoR is a type I transmembrane protein that belong to the cytokine receptor family [11] . Binding of Epo to EpoR induces a conformational change in the receptor complex and triggers a cascade of intracellular events including signaling by janus kinase 2 (JAK2) and signal transducer and activator of transcription 5 (STAT5) [12] . In hematopoietic cells, this cascade stimulates the rapid formation of functional red blood cells (RBCs) [9] . However, EpoR is also expressed in nonhematopoietic cells including endothelial cells and cells of the central nervous system, where it is mainly involved in regulating cell proliferation [13] . Based on the studies have shown that Epo increases the tyrosine phosphorylation of PLC-γl [14, 15] , these findings suggest that PLC-γl may be involved in Epo/EpoR complex-mediated signal transduction. However, this potential signaling pathway has not been studied in detail.
Here, we report that EpoR protein level was substantially decreased in PLC-γl cells. Such EpoR downregulation, which was largely dependent on rapid proteosomal degradation, resulted in decreased levels of PLC-γl-mediated cell adhesion and migration. Consistent with these findings, the EpoR expression levels were low in clinical samples from colorectal tumors showing high-level expression of PLC-γl.
Materials and methods
Cells and reagents Rat 3Y1 fibroblasts were transfected with empty pREFA, pREFA-PLC-γl, or pREFA-v-Src. Cells stably expressing PLC-γl or v-Src were isolated by growth at 37°C under 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) containing hygromycin (for selection) and 10% fetal calf serum (FCS). The polyclonal antibodies against phospho-tyrosine, EpoR, phospho-EpoR (pY-456), epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase2 (ERK2), phospho-ERK1/2 (Thr-177/Thr-160), janus kinase2 (JAK2), signal transducer and activator of transcription5 (STAT5) and phospho-STAT5 (pY-694) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The antibodies against paxillin, phospho-paxillin, PLC-γl and phospho-JAK2 (pY1007/ 1008) were obtained from Cell Signaling Technology (Beverly, MA). A mammalian expression vector containing a full-sized mouse EpoR gene was purchased from InvivoGen (San Diego, CA). The rat recombinant erythropoietin (Epo), the inhibitor of proteosome-mediated protein degradation (MG132), the inhibitor of lysosome-mediated protein degradation (bafilomycin), and the fluorescein isothiocyanate (FITC)-conjugated anti-rabbit immunoglobulin G (IgG) were obtained from Sigma-Aldrich (St. Louis, MO).
Immunofluorescence staining Cells were grown on glass coverslips, washed in PBS, fixed with 4% formaldehyde, and then permeabilized with 0.5% Triton X-100. After being blocked with phosphate buffered saline (PBS) containing 5% bovine serum albumin (BSA), the coverslips were incubated with antibodies against EpoR, phospho-EpoR, or phosphopaxillin for 16 h, and then further incubated with a FITCconjugated anti-rabbit IgG secondary antibody for 2 h at room temperature. The coverslips were stained and mounted, and images were collected using a Nikon Eclipse TE-2000 confocal microscope (Perkin-Elmer Life Science Inc., MA, USA).
Tet-off cell lines PC12 cells (Tet-Off cell line) were stably transfected with FLAG-tagged PLC-γl, and cultured in DMEM with 10% horse serum, 5% fetal bovine serum, 100 μg/ml G418, 100 μg/ml hygromycin B, 2 μg/ml tetracycline). PLC-γl was induced in medium without tetracycline.
Immunoblot analysis The 3Y1 fibroblasts were washed with cold PBS and then lysed in lysis buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 1% Nonidet P-40). Equal amounts of protein were fractionated on 10% polyacrylamide gels, and the antigen-antibody complexes were detected using the LumiGlo reagent (New England Bio Labs, Ipswich, MA).
RNA isolation and semi-quantitative RT-PCR RNA was prepared using the TRIzol reagent (Life Technologies, Gaithersburg, MD) and reverse transcription (RT) was performed as previously described [16] . The resulting product (1 μl) was PCR amplified with primers specific to rat EpoR (sense, 5-CTCTTACCAGCTCGAAGGTGA-3 and antisense, 5-TCCAGGACCTCCACCCTTTGT-3; 363 bp product). Actin was amplified as the internal control. The PCR reactions were conducted with the optimal number of cycles (94°C for 1 min, 58°C for 1 min, and 72°C for 1 min), and the generated PCR products did not reach saturation during the determined (optimal) number of cycles.
Preparation of tissue samples from colorectal cancer patients Tissue samples were obtained from four colorectal cancer patients (four males; mean age=61 years) undergoing surgery at the Chungnam National University Medical Center (Daejeon, Korea). Primary colorectal tumors and normal adjacent tissues were harvested under an institutional review board-approved protocol, and the samples were immediately frozen in liquid nitrogen and stored at −80°C.
Cell migration assay The migratory properties of PLC-γl and vector cells were measured using the CytoSelect™ 24-well cell migration assay (Cell Bio Labs, Inc., San Diego, CA). The cells (5×10 4 /well) were resuspended in 300 μl serum-free medium per well and placed in the upper chambers of the apparatus. Medium supplemented with 10% FBS was placed in each bottom well as a migrationpromoting agent, and the plate was incubated at 37°C under 5% CO 2 for 12 h. The upper chamber cells were removed, and migratory cells (those found under the polycarbonate membrane) were stained. The cells were washed with water and transferred to extraction solution [17] , and the absorbance of the extracted samples was measured at 560 nm using a microplate reader (Sunrise; Tecan, Switzerland). For the inhibition of proteosomal protein degradation and JAK2 kinase activity, cells in the upper chambers were treated with MG132 (1 ug/ml) and AG490 (20 μM), respectively, for 12 h.
Immunohistochemistry (IHC) Tissue sections were subjected to microwave heating for antigen retrieval and followed by incubation with 1.5% normal horse serum for 30 min in a humidifier (to block nonspecific protein affinity). The sections were then incubated with polyclonal rabbit anti-phospho-EpoR (diluted 1:200) followed by incubation with a biotinylated secondary antibody for 2 h. An avidin-biotinylated enzyme complex (ABC) kit, and a 3,3′-diaminobenzidine (DAB) substrate kit (Vector Laboratories, Burlingame, CA) were used to process the sections. The sections were counterstained with hematoxylin, fixed and then mounted and observed under a microscope. Statistical analysis The results are presented as mean values±SEM. Data were analyzed using the SIGMA-STAT software (Jandel Scientific Software, San Rafael, CA). Analyses of variance with protected t tests were used for intergroup comparisons.
Results
Erythropoietin receptor (EpoR) is downregulated in cells transformed by PLC-γ1 overexpression Although PLC-γl is known to be directly involved in cell migration and metastasis [1, 2, 5, 18] , the molecular mechanism underlying these effects is not yet fully understood. To investigate the signaling events involved in PLC-γ1-mediated cell migration and metastasis, we compared various characteristics between several 3Y1 fibroblast control clones transfected with empty vector (vector cells) and clones transformed by PLC-γ1 overexpression (PLC-γ1 cells) in which PLC-γl overexpression and cell transformation were confirmed [2] . As shown in Fig. 1a , total EpoR expression was markedly lower in PLC-γl versus vector cells, whereas the expression level of ERK2, another signaling protein known to be involved in cell proliferation [19] , was not affected by PLC-γl overexpression (Fig. 1a) . In addition, EpoR proteins phosphorylated at tyrosine 456 were clearly observed in vector controls but not in PLC-γl cells. An immunoprecipitation analysis also confirmed that immunoprecipitant obtained from PLC-γl cells contained significantly less tyrosinephosphorylated EpoR than that of vector cells (Fig. 1a , right panel). Treatment of cells with the tyrosine phosphatase inhibitor, sodium orthovanadate (SOV) [20] did not affect the levels of tyrosine-phosphorylated EpoR in PLC-γl or vector cells (data not shown), suggesting that the abrogation of tyrosine-phosphorylated EpoR in PLC-γl cells primarily reflected the marked decrease in EpoR expression.
To assess the effect of PLC-γ1 on EpoR downregulation further, we employed Tet-Off PC12 cells stably transfected with FLAG-tagged PLC-γ1-wild type (PLC-γ1-WT) [21] . When induced in the absence of tetracycline, upregulation of PLC-γ1-WT caused a marked decrease in EpoR expression and phosphorylation levels in a time dependent manner, while the expression of epidermal growth factor receptor (EGFR) was not affected (Fig. 1b) . Increased expression levels of FLAG-tagged PLC-γl were detected by a FLAG antibody.
Since overexpression of v-Src also causes cellular transformation [22] , we next examined the expression and phosphorylation levels of EpoR in cells transformed by PLC-γ1 or v-Src. Interestingly, v-Src-transformed cells showed higher increases in the expression and phosphorylation levels of EpoR than that of PLC-γ1 cells (Fig. 1c) , suggesting that the expression and phosphorylation levels of EpoR may vary in transformed cells. Immunofluorescence staining using an antibody against total EpoR showed that EpoR was distributed between the cytosol and cell membrane in vector cells, whereas it was found primarily in the cytosol of PLC-γl cells (Fig. 1d, arrowheads) . Immunofluorescence staining with an antibody against phosphorylated EpoR yielded a measurable signal at the plasma cell membrane of vector cells (Fig. 1d, arrowheads) , but this signal was largely abrogated in PLC-γl cells.
PLC-γl-transformed cells are insensitive to Epo We then assessed the effect of Epo in vector and PLC-γl cells maintained in serum-free medium for 48 h to remove possibly Epo contamination. Prior to Epo treatment, vector cells had clearly detectable levels of phosphorylated EpoR, STAT5, and Fig. 2 Epo treatment activates EpoR-dependent signaling in PLC-γl cells. a Vector and PLC-γl cells were maintained in serum-free medium for 48 h, and then treated with Epo (5 U/ml) for the indicated times. Cell lysates were resolved on a 10% polyacrylamide gel and then probed with antibodies against EpoR, phospho-EpoR, STAT5, phospho-STAT5, JAK2, phospho-JAK2 or β-actin. b The effect of serum on EpoR-dependent signaling pathways. Cells were serum starved for 48 h and then exposed to 10% serum for the indicated times. The results shown are representative of three separate experiments JAK2, whereas PLC-γl cells did not (Fig. 2a) . Following Epo exposure (5 U/ml), the levels of these phosphorylated proteins were significantly increased in vector cells, but remained undetectable in PLC-γl cells. Similar results were obtained in cells stimulated with serum which is likely to contain Epo (Fig. 2b) . All Epo and serum treatment did not affect the expression levels of these proteins. (Fig. 2a and b) . These findings suggest that the downregulation of EpoR in PLC-γl cells results in a low sensitivity to Epo. (Fig. 3a) , indicating that transcription was not altered. To assess whether EpoR protein degradation was altered, PLC-γ1 and vector cells were treated with a proteosomal protein degradation inhibitor (MG132) for 1 or 3 h, and examined the levels of EpoR. As shown in Fig. 3b , MG132 treatment significantly recovered the expression and phosphorylation of EpoR, and phosphorylation of JAK2 in PLCγl cells, but had no effect on EpoR expression and phosphorylation in vector cells. Expression of paxillin, a focal adhesion protein, and epidermal growth factor receptor (EGFR) were not affected by MG132 treatment in vector or PLC-γl cells (Fig. 3b) . To assess whether proteosomal degradation of EpoR was associated with ubiquitination, we immunoprecipitated lysates from MG132-treated PLC-γl cells with an anti-EpoR antibody and performed immunoblot analysis with an anti-ubiquitin antibody. As shown in Fig. 3c , EpoR increased by MG132 exhibited a marked ubiquitination (Fig. 3c) . Notably, treatment with the lysosomal protein degradation inhibitor, bafilomycin [23] , failed to recover EpoR expression in PLC-γl cells (Fig. 3d) . Expression of paxillin was not affected in PLCγl cells treated with MG132 or bafilomycin (Fig. 3d) . These results suggest that the PLC-γl-induced downregulation of EpoR involves ubiquitin-mediated proteosomal degradation but not lysosomal degradation.
PLC-γl overexpression induces degradation of EpoR
PLC-γl cells show reduced cell adhesion and migration Since we noted that although vector cells showed typical fibroblast morphologies, PLC-γl cells were rounded [3] , we compared the adhesive activity in PLC-γl and vector cells. Vector and PLC-γl cells were detached with trypsin-EDTA and plated on glass substrata in medium. 30, 60 and 180 min later, the Fig. 3 PLC-γl-induced EpoR downregulation is associated with proteosomal degradation. a Total RNA was isolated from vector and PLC-γl cells, first-strand cDNA was synthesized using reverse transcriptase (see Section 2), and EpoR and β-actin were PCR amplified with AmpliTaq DNA polymerase. The results shown are representative of three separate experiments. b Vector and PLC-γl cells were treated with MG132 (1 μg/ml) for 1 and 3 h. Cell lysates were subjected to 10% polyacrylamide gel electrophoresis and blots were probed with antibodies against EpoR, phospho-EpoR, phospho-JAK2, EGFR, paxillin or β-actin. c PLC-γl cells treated with MG132 for 2 h were lysed, EpoR proteins were immunoprecipitated, and the immunoprecipitant was probed with antibodies against ubiquitin or EpoR. d PLC-γl cells were treated with the lysosomal degradation inhibitor, bafilomycin (200 nM), or the proteosomal protein degradation blocker, MG132, for 1 and 3 h. The results shown are representative of three separate experiments adherent cells were counted from five random fields under light microscope. As shown in Fig. 4a , many vector cells adhered to the glass substratum within 30 min, and the number of adherent cells significantly increased up to 180 min. In contrast, four-fold fewer PLC-γl cells adhered to the glass substratum within 30 min, and this number increased only slightly by 180 min (Fig. 4a and b) . Interestingly, MG132 treatment significantly increased the number of adherent PLCγl cells (Fig. 4a and b) , and the amount of cell spreading was similar to that seen in vector cells (Fig. 4a, right side,  arrowheads) . Based on these findings, we next compared the migratory capacity of PLC-γl and vector cells. A serum-based chemotaxis assay revealed that PLC-γl cells migrated more slowly than vector cells (Fig. 4c) , whereas MG132-treated PLC-γl cells migrated significantly faster than DMSOtreated PLC-γl cells (Fig. 4d, left panel) . In vector cells, inhibition of JAK2 with AG490 significantly reduced cell migration although EpoR was highly expressed (Fig. 4d right  panel) . These results suggest that the decreased migration of PLC-γl cells is due at least in part to downregulation of EpoR and subsequent effects on cell adhesion.
PLC-γl overexpression decreases cell adhesion via downregulation of Epo/EpoR-dependent signaling To further assess the signaling involved in PLC-γl-mediated changes in cell adhesion, we maintained cells in serum-free medium for 48 h, exposed them to Epo for 10, 30 and 60 min, and examined various factors, including paxillin, a focal contact protein previously shown to be dephosphorylated in PLC-γl-transformed cells [3] . Epo stimulation ) were suspended in 300 μl serum-free medium per well and placed in the upper chambers of transwell plate. Serum was added to the bottom wells as a migration promoting agent, the plates were incubated for 12 h, the migratory cells were stained, and absorbance was measured at 560 nm; *p<0.05 versus vector cells. d PLC-γl and vector cells were treated with DMSO, MG132, or AG490 (20 μM) for 12 h, and then subjected to the above-described cell migration assay. *p<0.05 versus nonstimulated cells (medium control) significantly increased the phosphorylation of paxillin but not ERK2 in vector cells, and the extent was consistent with the phosphorylation of EpoR (Fig. 5a ). However, Epo had no effect on paxillin phosphorylation in PLC-γl cells (data not shown). A BrdU uptake experiment also revealed that Epo treatment had no effect on the proliferation of vector or PLC-γl cells (data not shown). Immunofluorescence staining with an anti-phospho-paxillin antibody to detect focal contact formation showed that Epo treatment strongly increased focal contact formation and that this effect was significantly reduced by AG490-mediated inhibition of JAK2 (Fig. 5b) . Interestingly, MG132 treatment recovered the expression and phosphorylation of EpoR in PLC-γl cells (Fig. 5c) . A marked increase in EpoR phosphorylation was elicited in PLC-γl cells treated with MG132 alone whereas the extent was lower than that of cells treated with Epo and MG132 together (Fig. 5c) . The level of phosphorylation of paxillin in cells treated with MG132 plus Epo were also significantly higher than that of cells treated with MG132 alone (Fig. 5c) , suggesting that EpoR upregulated by MG132 inhibition of protein degradation is functionally active in PLC-γl cells and responds to Epo stimulation. Moreover, we found that focal contacts were formed only weakly in PLC-γl cells, but this signal was significantly increased following MG132 treatment (Fig. 5d) . Cotreatment of Epo with MG132 stimulated cell spreading as well as adhesion in PLC-γl cells (Fig. 5d, arrowheads) . These results collectively suggest that EpoR primarily regulates cell adhesion not proliferation in fibroblasts, and PLC-γl overexpression downregulates this mechanism.
Overexpression of mouse EpoR in rat fibroblasts downregulates EpoR-dependent signaling pathways and cell migration As we had observed that EpoR-dependent signaling was downregulated in PLC-γl cells, we next assessed whether overexpression of EpoR in PLC-γ1 cells could rescue EpoR-dependent signaling pathways. To this end, PLC-γl cells and vector cells (rat fibroblasts) were transfected with the mouse EpoR gene and the phosphorylation levels of STAT5 and paxillin, and cell migratory activity were measured. Unexpectedly, overexpression of mouse EpoR significantly downregulated phosphorylation of JAK2, Fig. 5 The reduced cell adhesion of PLC-γl-overexpressing cells is due to EpoR downregulation. a Confluent vector cells were treated with Epo (5 U/ml) for the indicated times, cell lysates were separated on a 10% polyacrylamide gel, and blots were probed with an antibodies against phospho-EpoR, phospho-ERK1/2, phospho-paxillin, paxillin and β-actin. The results shown are representative of three separate experiments. b Vector cells were treated with medium, Epo (5 U/ml), AG490 (20 μM), or Epo plus AG490 for 2 h and fixed in 4% paraformaldehyde. After incubation for 20 min, immunofluorescence staining with a phospho-paxillin antibody was conducted. The images shown are representative of three separate experiments. c PLC-γl cells were treated with MG132 (1 μg/ml), or MG132 plus Epo for the indicated times. d PLC-γl cells were treated with medium, DMSO, MG132, or Epo plus MG132 for 2 h. After incubation, immunofluorescence staining with a phospho-paxillin antibody was conducted. The results shown are representative of three separate experiments STAT5, and paxillin in both vector and PLC-γl cells (Fig. 6a) . In particular, PLC-γl cells that showed lower-level EpoR expression than vector cells exhibited higher level of dephosphorylation of these proteins. Overexpression of mouse EpoR in PLC-γl cells resulted in a greater level of cell rounding than seen in cells transfected with empty vector (Fig. 6b) , suggesting a reduction in cell adhesion. A marked decrease in cell migration following mouse EpoR overexpression was also confirmed in both vector and PLCγl cells (Fig. 6c) . However, overexpression of mouse EpoR in a mouse fibroblast line, NIH3T3, did not affect EpoRdependent activation of JAK2, STAT5, or paxillin (Fig. 6d) . Moreover, there was no mouse EpoR-mediated reduction of cell migration (Fig. 6e) . These results suggest that mouse EpoR acts as a dominant-negative gene in rat fibroblasts. Sequence comparison of the mouse and rat EpoR genes revealed a 5% mismatch in DNA sequence, which might explain the different protein properties of the two species. Overall, our findings suggest that EpoR of fibroblasts is involved in cell adhesion and migration, and this is primarily regulated by PLC-dependent pathways.
EpoR-dependent activation of paxillin is downregulated in PLC-γ1-overexpressing human colorectal cancer tissues Finally, we examined the expression and phosphorylation levels of EpoR and paxillin in colorectal tumor tissues showing high-level expression of PLC-γl. Immunoblot analysis revealed significantly lower expression and phosphorylation levels of EpoR and paxillin in PLC-γl-overexpressing colorectal tumor samples versus adjacent normal mucosa (Fig. 7a) . However, ERK2 expression was not significantly different in PLC-γl-overexpressing colorectal tumor tissues versus normal controls. Immunohistochemical analysis with an anti-phospho-EpoR antibody showed that phosphorylated EpoR was strongly detected in the crypts and weakly at the surface epithelium of normal colon epithelial cells, but no such staining was observed in colonic tumor tissues in which PLC-γl was highly expressed (Fig. 7b ).
Discussion
Studies have shown that PLC-γl can mediate cellular transformation and that PLC-γl plays critical roles in both cell adhesion and migration [1-3, 7, 24] . Sala et al. showed that downregulation of PLC-γl inhibited human breast cancer cell-derived lung metastasis in mice [25] . However the molecular mechanism underlying PLC-γl-dependent cell migration and metastasis has not been studied in detail. Here, we show for the first time that EpoR is present on nonhematopoietic rat fibroblasts, and that EpoR can increase cell adhesion (cell-matrix adhesion) via paxillin phosphorylation, subsequently affecting cell migration. However, Epodependent cell adhesion and migration were significantly decreased in cells overexpressing PLC-γl (PLC-γl cells). These findings suggest that cells transformed by PLC-γl overexpression show a decrease in cell adhesion associated with paxillin dephosphorylation resulting, in turn, from proteosomal degradation of EpoR. Such lowered cell adhesion (cell-matrix adhesion) may be associated with dissemination of cells from a primary tumor mass and subsequent metastasis. Consistent with this idea, overexpression of an inactive mutant of paxillin has been shown to impair the motility of rat bladder carcinoma cells [26] .
As PLC-γl potentiates integrin-dependent cell spreading and migration through a process mediated by activation of Pyk2/paxillin [27] , and as integrin-dependent PLC-γl phosphorylation in turn controls fibronectin-dependent adhesion [28] , our findings that cells overexpressing PLC-γl exhibited significantly decreased cell adhesion and migration upon paxillin dephosphorylation appear to be contrary to expectations. However, given that phosphorylation of paxillin is crucial for cell adhesion and migration [29, 30] , and that paxillin-null fibroblasts show reduced rates of cell spreading and migration [31] , the results of our current study indicate a clear correlation between the paxillin dephosphorylation seen in PLC-γl cells and the decrease in cell adhesion, which in turn influences migration. Chang et al. also found that overexpression of PLC-γl markedly decreased the phosphorylation of paxillin in, and cell adhesion by, rat fibroblasts [3] .
The Epo/EpoR system not only stimulates red blood cell proliferation [32, 33] , it can also act in nonhematopoietic tissues and cells [13] . In cases where EpoR is degraded, this degradation may occur after formation of the Epo/EpoR complex, thereby leading to a rapid decrease of the cell's Epo responsiveness. Indeed, Walrafen et al. reported that following ligand binding, EpoR was quickly ubiquitinated and degraded by the proteosome system [12] . Here, we demonstrated that overexpression of PLC-γl induced ubiquitination and proteosome-mediated degradation of EpoR in fibroblasts. This observation indicates a new regulatory role for PLC-γl in regulating turnover rate of protein via ubiquitination. Given that the RA2 domain located in the tail region of the phospholipase, PLC-ε, mediates phospholipase degradation via interaction with the ubiquitin E3 ligase [34] , we speculate that PLC-γl may be indirectly involved in activation of ubiquitination and subsequent proteosomal protein degradation. The PLC-γl-induced proteosomal degradation of EpoR, and the subsequent decreases in paxillin phosphorylation and cell-matrix adhesion, also suggest that EpoR and associated signaling molecules are likely to be critical targets for PLC-γl-dependent cell liberation from a primary tumor mass, followed by metastasis.
Based on observations that many tumor samples and cancer cell lines express high levels of EpoR [35] [36] [37] , many investigators have speculated that administration of Epo to cancer patients may promote tumor growth [38] [39] [40] . However, Epo treatment does not appear to alter the viability or growth rate of tumor cell lines in vitro [41] , and EpoR does not appear to be consistently altered in tumor samples [14, 42] . We would argue that the latter result may reflect, at least in part, the nonspecificity of the antibodies used to detect EpoR. For example, the C-20 polyclonal anti-EpoR antibody has been reported to cross-react with heat-shock protein HSP70 [41] . Here, we used the M-20 polyclonal anti-EpoR antibody, which has been shown to be relatively specific for EpoR [41] . We found that cells transformed by PLC-γl overexpression exhibited lower EpoR expression compared to vector cells. Consistent with this, we observed noticeably less EpoR expression in PLC-γl-overexpressing colorectal cancer tissues versus normal adjacent samples. Our finding contrasts with previous studies showing increased EpoR expression in colorectal cancer cells [35] [36] [37] . This discrepancy is likely to be associated with whether or not the tumorigenesis involved PLC-γl, potentially suggesting that PLC-γl may help determine the diverse levels of EpoR expression seen in various cell types.
In summary, we herein showed that cells transformed by PLC-γl overexpression were characterized by ubiquitination and proteosomal degradation of EpoR, which in turn resulted in decreased cell adhesion and migration. Our findings strongly suggest that the Epo/EpoR complex plays a key role in cell adhesion of nonhematopoietic fibroblasts, and that its functional inactivation appears to be associated with PLC-γl-dependent regulation of cell migration and metastasis.
